Action details
Memorandum of Understanding
CSO Approval date
Start of Action
End of Action
Research Outputs
Updates on the research outputs of CliniMARK are provided on this page.
International peer-reviewed journal articles
CliniMARK working papers
Related publications
Management Committee & Working Group Leaders
News & Events
Don´t miss this calls
Understanding causative mechanisms in co- and multimorbidities
Publication date: 27 October 2017
Types of action: RIA Research and Innovation action
Deadline Model: two-stage
Planed opening: 26 July 2018
Systems approaches for the discovery of combinatorial therapies for complex disorders
Publication date: 27 October 2017
Types of action: RIA Research and Innovation action
Deadline Model: two-stage
Planed opening: 26 July 2018
(Posted on 23 July 2018)
Publication date: 27 October 2017
Types of action: RIA Research and Innovation action
Deadline Model: two-stage
Planed opening: 26 July 2018
Systems approaches for the discovery of combinatorial therapies for complex disorders
Publication date: 27 October 2017
Types of action: RIA Research and Innovation action
Deadline Model: two-stage
Planed opening: 26 July 2018
(Posted on 23 July 2018)
ROBoCoP: a Respiratory disease Occupational Biomonitoring Collaborative Project
Chronic obstructive pulmonary disease (COPD) is a major public health problem with a prevalence in Switzerland reaching 15.9% in men. Exposure to particulate matter (PM) is a known COPD risk factor via oxidative stress pathway. Reactive oxygen species (ROS) and their metabolites could be predictive to COPD onset and be used as diagnostic biomarkers.
ROBoCop project, in the framework of CliniMark EU-COST Action, aims to select and validate a panel of oxidative stress biomarkers analyzed in non-invasive biological samples. (Posted on 11 January 2018)
ROBoCop project, in the framework of CliniMark EU-COST Action, aims to select and validate a panel of oxidative stress biomarkers analyzed in non-invasive biological samples. (Posted on 11 January 2018)
Conference Validation of biomarkers October 6th 2017, De Doelen - ICC Rotterdam
Translating biomarker candidates from discovery to the clinic remains a challenge. This conference examines how integrated technologies can bridge the innovation gap.
Waters MS Technology Days 2017: Evaluation of biomarkers predictive for Alzheimer's disease
During the Waters MS Technology Days 2017 in Basel (6/27) and Lausanne (6/27) research results were presented from a BDC study carried out in the group of Dr. Theo Luider at the Erasmus MC (Rotterdam) about development and application of an LC-MS assay to evaluate Pregnancy Zone Protein as potential biomarker for the prediction of Alzheimer's disease. Information about the meeting here.(Posted on 24 August 2017)
EATRIS Conference, Prague, September 24-26, 2017
EATRIS, the European Infrastructure for Translational Medicine in which the BDC laboratories of profs Bischoff, Luider and van Gool are members, will hold its annual Translational Conference in Prague, September 24-26. Conference information here.
(Posted 17 May 2017)
Bridging the translational innovation gap through good biomarker practice
In collaboration with the European technology infrastructures EATRIS, BBMRI and ELIXIR, prof van Gool and other scientists from the Biomarker Development Center published a comment in Nature Reviews Drug Discovery to join efforts in defining the Good Biomarker Principle guidelines that will support successful biomarker discovery and development activities. These guidelines will be defined in the COST action CliniMARK, initiated and coordinated by dr Luider of the BDC. See comment here.
(Posted 10 May 2017)
CliniMARK Kick-off meeting
The CliniMARK network has the goal of establishing "Best Biomarker Practice" (BBP) guidelines to radically improve the process from biomarker discovery to clinical use. The kick-off meeting was held at the COST offices in Brussels on March 14, 2017. A plan was developed to define BBP guidelines and to apply these guidelines for the validation of biomarkers with COPD as an example. The next meeting will be held from October 5 to 7, 2017, at the Erasmus MC (Rotterdam) in conjunction with the Biomarker Symposium. For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it..
(Posted 20 March 2017)
